• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

已发表的药品不良事件报告的质量。

The quality of published adverse drug event reports.

作者信息

Kelly William N

机构信息

Department of Administrative and Clinical Sciences, School of Pharmacy, Mercer University, 3001 Mercer University Dr., Atlanta, GA 3034-4155.

出版信息

Ann Pharmacother. 2003 Dec;37(12):1774-8. doi: 10.1345/aph.1D202.

DOI:10.1345/aph.1D202
PMID:14632590
Abstract

BACKGROUND

Case reports of adverse drug events (ADEs) are an important source of information.

OBJECTIVE

To determine what variables are reported in ADE case reports, how causality was assessed for each report, and what criteria are specified for publishing ADE case reports.

METHODS

A descriptive analysis of highly significant ADE case reports published in English over a 20-year period was performed. Main outcome measures included frequency distributions for the types of variables reported. The presence of causality assessment and the criteria for submitting an ADE report to practitioner journals were also examined.

RESULTS

A highly significant ADE was described in 1520 published case reports during the study period. Three patient variables were reported >90% of the time, while 12 others were reported <25% of the time. Only 1 drug variable was reported >90% of the time; 6 others were reported 14-74% of the time. Most of the relevant ADE variables were reported most often. Added information for drug interactions, medication errors, and allergic drug reactions were reported 61-99% of the time. Less than 1% of ADE reporters objectively assessed the probability of the ADE. All but one journal publishing the most ADE reports did not require such assessment.

CONCLUSIONS

Professional journals might consider stricter requirements for publishing ADE reports. As a minimum, requirements should include an objective assessment of ADE causality, with explicit recognition in the published text and abstract of the report.

摘要

背景

药品不良事件(ADEs)的病例报告是重要的信息来源。

目的

确定ADE病例报告中报告了哪些变量,每份报告如何评估因果关系,以及发布ADE病例报告规定了哪些标准。

方法

对20年间以英文发表的具有高度显著性的ADE病例报告进行描述性分析。主要观察指标包括所报告变量类型的频率分布。还检查了因果关系评估的存在情况以及向医学专业期刊提交ADE报告的标准。

结果

在研究期间,1520份已发表的病例报告中描述了具有高度显著性的ADE。三种患者变量报告频率>90%,而其他12种报告频率<25%。只有一种药物变量报告频率>90%;其他六种报告频率为14%-74%。大多数相关的ADE变量报告频率最高。药物相互作用、用药错误和药物过敏反应的补充信息报告频率为61%-99%。不到1%的ADE报告者客观评估了ADE的可能性。除一份发表ADE报告最多的期刊外,所有期刊都没有要求进行此类评估。

结论

专业期刊可能应考虑对发表ADE报告提出更严格的要求。至少,要求应包括对ADE因果关系的客观评估,并在报告的发表文本和摘要中明确体现。

相似文献

1
The quality of published adverse drug event reports.已发表的药品不良事件报告的质量。
Ann Pharmacother. 2003 Dec;37(12):1774-8. doi: 10.1345/aph.1D202.
2
Inter-rater reliability of a classification system for hospital adverse drug event reports.医院不良药物事件报告分类系统的评分者间信度
Clin Pharmacol Ther. 2008 Mar;83(3):485-8. doi: 10.1038/sj.clpt.6100322. Epub 2007 Aug 22.
3
Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration.自发触发不良事件报告的质量评估,这些报告由食品和药物管理局收到。
Pharmacoepidemiol Drug Saf. 2012 Jun;21(6):565-70; discussion 571-2. doi: 10.1002/pds.3223. Epub 2012 Feb 22.
4
Adverse drug event reporting in intensive care units: a survey of current practices.重症监护病房中的药品不良事件报告:当前实践情况调查
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1267-73. doi: 10.1345/aph.1H088. Epub 2006 Jul 18.
5
Performance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance system.《国际疾病分类第九版临床修订本》编码作为药品不良事件监测系统的效能
Med Care. 2006 Jul;44(7):629-36. doi: 10.1097/01.mlr.0000215859.06051.77.
6
Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database.伏立康唑的不良反应:法国药物警戒数据库分析
Ann Pharmacother. 2007 May;41(5):755-63. doi: 10.1345/aph.1H671. Epub 2007 Apr 24.
7
Medication safety program reduces adverse drug events in a community hospital.药物安全项目降低了社区医院的药物不良事件。
Qual Saf Health Care. 2005 Jun;14(3):169-74. doi: 10.1136/qshc.2004.010942.
8
A pharmaceutical manufacturer's perspective on reporting adverse drug experiences.制药商对药品不良反应报告的看法。
Am J Hosp Pharm. 1990 Jun;47(6):1342-5.
9
Effective interventions and implementation strategies to reduce adverse drug events in the Veterans Affairs (VA) system.在退伍军人事务部(VA)系统中减少药物不良事件的有效干预措施和实施策略。
Qual Saf Health Care. 2008 Feb;17(1):37-46. doi: 10.1136/qshc.2006.021816.
10
Risk factors for self-reported adverse drug events among Medicare enrollees.医疗保险参保人中自我报告的药物不良事件的风险因素。
Ann Pharmacother. 2008 Jan;42(1):53-61. doi: 10.1345/aph.1K073. Epub 2007 Nov 20.

引用本文的文献

1
ADR in Journals: Are They Translated into Regulatory Frameworks?期刊中的药品不良反应:是否被纳入监管框架?
Curr Drug Saf. 2022;17(1):34-39. doi: 10.2174/1574886316666210609115148.
2
Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese Children.中国儿童使用的中药注射剂的安全性问题
Evid Based Complement Alternat Med. 2019 Jun 23;2019:8310368. doi: 10.1155/2019/8310368. eCollection 2019.
3
Development of an adverse events reporting form for Korean folk medicine.韩医不良事件报告表的开发。
Pharmacoepidemiol Drug Saf. 2017 May;26(5):498-508. doi: 10.1002/pds.4077. Epub 2016 Aug 8.
4
Accuracy of Adverse Drug Reaction Documentation upon Implementation of an Ambulatory Electronic Health Record System.门诊电子健康记录系统实施后药物不良反应记录的准确性
Drugs Real World Outcomes. 2016 May 4;3(2):231-238. doi: 10.1007/s40801-016-0071-8. eCollection 2016 Jun.
5
Development of a quality instrument for assessing the spontaneous reports of ADR/ADE using Delphi method in China.在中国使用德尔菲法开发一种用于评估药品不良反应/药物不良事件自发报告的质量工具。
Eur J Clin Pharmacol. 2016 Sep;72(9):1135-42. doi: 10.1007/s00228-016-2081-6. Epub 2016 Jun 16.
6
Published cases of adverse drug reactions: has the quality of reporting improved over time?已发表的药物不良反应病例:报告质量是否随时间有所提高?
Ther Adv Drug Saf. 2015 Apr;6(2):38-44. doi: 10.1177/2042098615569725.
7
Postmarketing adverse drug reactions: A duty to report?药品上市后不良反应:报告义务?
Neurol Clin Pract. 2013 Aug;3(4):288-294. doi: 10.1212/CPJ.0b013e3182a1b9f0.
8
Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.别嘌醇过敏反应:1950 年至 2012 年所有已发表病例的系统回顾。
Drug Saf. 2013 Oct;36(10):953-80. doi: 10.1007/s40264-013-0084-0.
9
Misuse of the Naranjo Adverse Drug Reaction Probability Scale in toxicology.滥用 Naranjo 药物不良反应概率量表进行毒理学研究。
Clin Toxicol (Phila). 2013 Jul;51(6):461-6. doi: 10.3109/15563650.2013.811588. Epub 2013 Jun 18.
10
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project.双膦酸盐类药物与股骨骨折不愈合:FDA 不良事件报告系统(FAERS)和国际安全工作的分析:来自不良药物事件和报告研究(RADAR)项目的系统评价。
J Bone Joint Surg Am. 2013 Feb 20;95(4):297-307. doi: 10.2106/JBJS.K.01181.